Puma Biotechnology informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de Puma Biotechnology utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
PBYI | Puma Biotechnology | $0.45 | $0.08 | — | — | $80.50M | $49.95M | — | — | 11/06/2025 | |
PBYI | Puma Biotechnology | -$0.05 | $0.07 | $0.15 | 114.29% | $47.10M | $51.27M | $49.20M | -4.04% | 08/07/2025 | |
PBYI | Puma Biotechnology | -$0.05 | $0.03 | $0.10 | 233.33% | $43.80M | $44.55M | $46.00M | 3.25% | 05/08/2025 | |
PBYI | Puma Biotechnology | $0.31 | $0.14 | $0.43 | 207.14% | $72.20M | $52.50M | $59.10M | 12.57% | 02/27/2025 | |
PBYI | Puma Biotechnology | $0.17 | $0.35 | $0.45 | 28.57% | $56.10M | $70.65M | $80.50M | 13.94% | 11/07/2024 | |
PBYI | Puma Biotechnology | $0.10 | -$0.10 | -$0.05 | 50.00% | $54.60M | $47.30M | $47.10M | -0.42% | 08/01/2024 | |
PBYI | Puma Biotechnology | $0.09 | -$0.22 | -$0.05 | 77.27% | $52.80M | $41.05M | $43.80M | 6.70% | 05/02/2024 | |
PBYI | Puma Biotechnology | -$0.07 | $0.30 | $0.31 | 3.33% | $65.70M | $73.55M | $72.20M | -1.84% | 02/29/2024 | |
PBYI | Puma Biotechnology | $0.05 | $0.08 | $0.17 | 112.50% | $57.10M | $57.95M | $56.10M | -3.19% | 11/02/2023 | |
PBYI | Puma Biotechnology | $0.28 | $0.07 | $0.10 | 42.86% | $59.50M | $51.37M | $54.60M | 6.29% | 08/03/2023 | |
PBYI | Puma Biotechnology | -$0.01 | -$0.07 | $0.09 | 228.57% | $45.70M | $49.63M | $52.80M | 6.39% | 05/04/2023 | |
PBYI | Puma Biotechnology | $0.21 | $0.01 | -$0.07 | -800.00% | $55.40M | $57.06M | $65.70M | 15.14% | 03/02/2023 | |
PBYI | Puma Biotechnology | -$0.99 | -$0.05 | $0.05 | 200.00% | $46.20M | $50.13M | $57.10M | 13.90% | 11/03/2022 | |
PBYI | Puma Biotechnology | $0.32 | — | $0.28 | — | $53.40M | $51.97M | $59.50M | 14.49% | 08/04/2022 | |
PBYI | Puma Biotechnology | $0.55 | -$0.17 | -$0.01 | 94.12% | $98.20M | $45.07M | $45.70M | 1.40% | 05/05/2022 | |
PBYI | Puma Biotechnology | -$0.14 | — | $0.21 | — | $52.60M | $47.17M | $55.40M | 17.45% | 03/03/2022 | |
PBYI | Puma Biotechnology | -$0.60 | -$0.31 | -$0.99 | -219.35% | $50.80M | $53.31M | $46.20M | -13.34% | 11/04/2021 | |
PBYI | Puma Biotechnology | $0.35 | -$0.34 | -$0.13 | 61.76% | $70.60M | $51.60M | $53.40M | 3.49% | 08/05/2021 | |
PBYI | Puma Biotechnology | -$0.43 | $0.09 | $0.55 | 511.11% | $51.20M | $71.47M | $98.20M | 37.40% | 05/06/2021 | |
PBYI | Puma Biotechnology | -$0.29 | -$0.29 | -$0.14 | 51.72% | $62.90M | $52.79M | $52.60M | -0.36% | 02/25/2021 | |
PBYI | Puma Biotechnology | -$0.44 | -$0.39 | -$0.60 | -53.85% | $56.40M | $53.05M | $50.80M | -4.24% | 11/05/2020 |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $0.15 | $0.07 | 114.3 % |
| Q1 | 2025-05-08 | $0.10 | $0.03 | 233.3 % |
| Q4 | 2025-02-27 | $0.43 | $0.14 | 207.1 % |
| Q3 | 2024-11-07 | $0.45 | $0.35 | 28.6 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $49.20M | $51.27M | -4.04 % |
| Q1 | 2025-05-08 | $46.00M | $44.55M | 3.25 % |
| Q4 | 2025-02-27 | $59.10M | $52.50M | 12.6 % |
| Q3 | 2024-11-07 | $80.50M | $70.65M | 13.9 % |
Está previsto que Puma Biotechnology (PBYI) presente resultados el noviembre 6, 2025. Los últimos resultados se publicaron el agosto 7, 2025 para el Q2.
El BPA real fue de $0.15, que superó la estimación de $0.07.
Los ingresos reales fueron $49.2M, que no alcanzó la estimación de $51.3M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.